MindMap Gallery Gilead Sciences Organizational Chart
This organizational chart reveals the intricate structure behind Gilead Sciences, a leader in biopharmaceutical innovation, highlighting a robust R&D-centered framework. Board of Directors oversees key committees: Governance (board composition), Science & Technology (R&D direction), Public Policy (government affairs). CEO is supported by Chief of Staff and strategic teams: Corporate Strategy (M&A, partnerships), Finance (capital allocation), Legal (IP, compliance), HR (talent), Communications. Core operations: Research & Development encompassing: Discovery Research: therapeutic areas (HIV, HBV, HCV, oncology, immunology, inflammation) – biology, chemistry, virology, protein engineering. Preclinical Development: pharmacology, toxicology, ADME, formulation. Clinical Development: Phase 1–3 trials (virology, oncology, inflammation), biostatistics, data management. Regulatory Affairs: FDA, EMA, global filings, post-market commitments. Medical Affairs: scientific communication, medical information, real-world evidence, investigator-initiated studies. Manufacturing: process development (scale-up), quality assurance (cGMP), production (small molecule, biologics, cell therapy), supply chain (logistics, distribution). Commercial: marketing (HIV, HCV, oncology), sales (account management), market access (payer negotiations, reimbursement), patient support (co-pay, adherence). This structure ensures efficient program management, quality assurance, and integration of cutting-edge technologies (cell therapy, gene editing, long-acting antivirals).
Edited at 2026-03-25 15:02:34